Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic Acid for Central Centrifugal Cicatricial Alopecia
NCT05416333Phase 1Active, not recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of azelaic acid 15% gel vehicle in central centrifugal cicatricial alopecia (CCCA) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Amount of hair loss regression at 6 months. Started Aug 2024; status: active, not recruiting.
02
Drugs
azelaic acid 15% gel vehicle
03
Conditions
central centrifugal cicatricial alopecia (CCCA)
Beyond the preview
Go deeper on NCT05416333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416333.